Application of personalized nursing based on dynamic monitoring of oral pH in oral management of patients with hematological diseases undergoing chemotherapy Authors: Xiao Zhang, Guoping Ren, Weiwei Qin, Zhuo Wan, Hua He, Wangbing Xue, Chenguang Zhou, Jizhen Yang Published: 2026 ABSTRACT To investigate the implications of salivary pH for the occurrence of oral mucositis (OM) in patients with hematological diseases during consolidation chemotherapy with high-dose cyclidine, and to evaluate the effect of personalized alkalization care guided by dynamic pH monitoring on the healing of oral ulcers in acidic subgroups. The study was conducted using a two-stage design. The first phase was a prospective cohort observation, which included 100 patients who received high-dose cytiabine (≥ 2 g/m2/ time) consolidation chemotherapy in the hematology department of a hospital from May 2024 to May 2025. They were uniformly given basic oral care and saliva pH and OM grades were recorded daily. OM was determined based on the occurrence of WHO oral mucositis grade ≥ 2 within a 28-day cycle. In the second stage, patients who developed OM in the first stage were selected for persistent acidic microenvironment (pH < 6.0 for ≥ 3 consecutive days), and randomized controlled trials (1:1 area randomization) were conducted to compare ulcer healing time between “pH monitoring guided alkalization care” and “routine care”, and to observe pH changes and pain VAS scores on the 3rd and 7th days after intervention. Statistical analysis, in addition to the conventional intergroup comparisons, supplemented multivariate models were used to adjust for outcomes (Logistic regression in the first stage, Cox regression or generalized linear model in the second stage), and effect sizes and 95% confidence intervals were reported. In the first stage, there were 53 cases of OM occurrence and 47 cases of no OM occurrence. The baseline pH difference was not statistically significant (6.32 ± 0.42 vs. 6.17 ± 0.39, P = 0.067). In the second stage, a total of 34 cases were included in the acidic subgroup, 20 in the intervention group, and 14 in the conventional group; The ulcer healing time in the intervention group was shorter than that in the conventional group (6.8 ± 1.2 d vs. 11.3 ± 2.1 d, P < 0.001), and the pH on the third day after intervention was higher than that in the conventional group (6.55 ± 0.15 vs. 6.09 ± 0.19, P < 0.001). A single baseline pH is difficult to serve as a universal early warning indicator for OM occurrence; In the persistent acidic microenvironment subgroup, personalized alkalization care guided by dynamic pH monitoring can accelerate the return of the oral microenvironment to neutrality and shorten the ulcer healing cycle. Introduction High-dose cytiabine (HDAC) is a common regimen in consolidation chemotherapy for hematological malignancies. Bone marrow suppression and mucosal cytotoxicity can induce oral mucositis (OM), which can cause pain, restricted eating, increased risk of secondary infection and disruption of treatment plans. The occurrence and development of OM involve epithelial damage, inflammatory amplification, ulcer formation and repair and reconstruction; The staging model proposed by Sonis suggests that clinically visible ulcers often occur after the amplification of the cascade reaction, and the early intervention window is often short and easily overlooked. The MASCC/ISOO mucositis guidelines list basic oral care as a core link, emphasizing proper cleaning, gentle rinsing, pain management and risk stratification management; A single “general regimen” often shows effect fluctuations in highly heterogeneous populations, and a stratified strategy is closer to the real clinical situation. Randomized controlled studies of radiotherapy-associated oral mucositis for head and neck tumors provide more direct clinical evidence for supportive treatment. Ibrahim’s team observed in a randomized controlled clinical trial that glutamine oral suspension intervention was accompanied by a decrease in salivary1 TGF-β1, reduced severity of mucositis and pain burden, decreased opioid usage rate, and reduced weight loss. The evidence suggests that oral complications are more likely to be validated if the intervention is anchored to observable indicators and outcome evaluations, and also provides an external basis for the “monitoring - stratification - intervention” approach of this study. Saliva pH reflects the buffering state of the oral cavity and the local microenvironment. The acidic environment promotes microbial adhesion and reproduction, and the release of inflammatory mediators is more active, with enhanced proteolytic activity in the wound surface, which may slow the epithelialization process. Clinical observations have found that some patients have a persistent acidic microenvironment after the onset of OM, and there is a temporal correlation between acidic fluctuations and changes in pain and ulcer area. Studies on oral complications in survivors of head and neck tumors after radiotherapy suggest that salivary changes can be a persistent burden. The Abou-Bakr team evaluated oral problems after radiotherapy from the periodontal health dimension in a cross-sectional study and discussed the associated factors2. The same team reported the occurrence of delayed dry mouth and low salivation in multicenter cross-sectional studies and quantified salivary system impairment and risk factors3 using metrics such as resting salivary flow rate. Combined with the above evidence, it can be inferred that reduced salivary secretion and decreased buffering capacity may push the oral microenvironment towards an acidic shift, thereby prolonging the mucosal repair process; Therefore, incorporating pH dynamic trajectories into oral care decisions has a clearer biological and clinical context. Based on this, this study adopts a two-stage design: first to test the strength of the association between “single pH at admission” and OM occurrence, and then to narrow the perspective to the “persistent acidic subgroup” to assess whether individualized alkalization care guided by dynamic monitoring can improve the microenvironment more quickly and accelerate healing. Data and methods General Information Basic information of the research subjects This study used a prospective design and included a total of 100 patients who received high-dose cytarabine (dose standard ≥ 2 g/m2/time) consolidation chemotherapy consecutively in the department of hematology of a hospital from May 2024 to May 2025. All patients completed disease assessment and general body examination before enrollment to confirm compliance with treatment and follow-up requirements. The gender ratio distribution of the study subjects was balanced, and the age range covered young to old age groups. There was no significant difference in the average age in the statistical test, suggesting that the groups were in a balanced state in terms of general demographic characteristics and had conditions for a controlled study. Inclusion and exclusion criteria The inclusion criteria were: ① pathologically confirmed acute leukemia; ② Performance status (ECOG) score less than 2; ③ Intact oral mucosa before chemotherapy; ④ The patient himself/herself and his/her family members sign the informed consent form. Exclusion criteria: ① Previous head and neck radiotherapy; ② Combined with salivary gland-related diseases; ③ Oral ulcers or obvious mucosal damage already present before the start of chemotherapy; ④ Accompanied by severe liver or kidney dysfunction, such as Child-Pugh grade C or an estimated glomerular filtration rate of less than 30 ml/min. Ethical approvals The study protocol was reviewed and approved by the hospital ethics committee prior to initiation. All subjects were fully informed of the study’s purpose, procedures, potential risks, and benefits, and each participant voluntarily provided written informed consent before enrollment. The study was conducted in strict accordance with the relevant principles of the Declaration of Helsinki, including its subsequent amendments. Methods Phase 1 study protocol (full cohort observational study) Fig. 1Flowchart of the research on personalized nursing intervention under dynamic monitoring of oral pH. Flowchart of the research on personalized nursing intervention under dynamic monitoring of oral pH. The study process is shown in Fig. 1. The study period was from May 2024 to May 2025. A total of 100 patients who received high-dose cytarabine (≥ 2 g/m2/ time) consolidation chemotherapy in the hematology department of our hospital were included consecutively. All subjects received a uniform oral care routine: 0.12% chlorhexidine mouthwash twice daily and soft-bristled toothbrush cleaning three times daily. From the first day of admission and the initiation of chemotherapy, trained nursing staff collected supringual saliva (with an accuracy of ± 0.01) on an fasting state in the early morning each day, recorded the daily variation trajectory of pH, and conducted daily assessment4 according to the WHO oral mucositis classification. WHO grading of oral mucositis: Grade 0 no mucositis; Grade 1 oral pain/erythema; Grade 2 erythema with ulcers and still able to consume solid food; Grade 3 ulcers are obvious and only liquid food is allowed; Grade 4 cannot be eaten orally. Grade 2 and above mucositis is determined as a positive endpoint; Those who did not reach grade 2 within the 28-day chemotherapy cycle were determined as negative endpoints. The primary observation measure was baseline pH (the first measurement at admission). Independent sample t-tests were used to compare baseline pH differences between the occurrence group (n = 53) and the non-occurrence group (n = 47) to assess whether the predictive value of salivary pH was universal for the population. A separate Logistic regression model was established, with the occurrence of mucositis (yes/no) as the dependent variable, baseline pH as the primary independent variable, and covariables including age, gender, type of diagnosis, chemotherapy cycle, minimum ANC OR duration of neutropenia, antibacterial/antifungal prophylaxis, and oral basic status at enrollment, reporting adjusted OR, 95%CI, and P values. Phase II study protocol (acidic subgroup RCT intervention study) Of the 53 cases with mucositis in the first stage, 34 cases with persistent acidic microenvironment (pH < 6.0 for ≥ 3 consecutive days) were screened out and assigned to two groups by block randomization. Trial registration: Completed on the clinical trial registration platform, and the registration information is publicly available on the registration page; The structure of the trial report refers to CONSORT 2010, with the inclusion, allocation, follow-up, and analysis steps presented in the flowchart. Sample size estimation: based on the primary outcome “mucosal healing time”, set the minimum clinical difference δ = 3.0 days between the two groups, standard deviation σ = 2.5 days, bilateral α = 0.05, test efficacy 0.80, and calculate a minimum of 11 cases per group; After being upregulated at 10% dropout, the target sample size for each group was 13 cases. Random sequence generation: Computer-generated block random sequences (block size 4) from individuals not involved in enrollment and intervention implementation. Allocation hiding: Use opaque, sealed, sequentially numbered envelopes to keep the grouping information, and open the envelopes in the order of the numbers after the subjects have completed enrollment to determine the grouping. ① Targeted intervention group (n = 20) : Individualized alkalization regimens were implemented on the basis of routine care, and saliva pH was monitored in the morning and evening every day; When pH < 6.0, initiate 4% sodium bicarbonate mouthwash every 4 h; Pause alkalization when pH ≥ 6.0. ② Routine care group (n = 14) : Maintain the basic care routine of the first stage5. Both groups began intervention on the day of diagnosis of mucositis until the wound was completely epithelialized with no bleeding and no pseudomembrane coverage. The primary outcome was mucosal healing time (daily image retention, double-blind interpretation); Secondary outcomes were pH changes on day 3 and day 7 after intervention, as well as the VAS score for wound pain (0–10 points). Blinding: No blinding between the care performers and the subjects; Image interpretation is independently performed by two assessors who do not know the grouping information, and a third assessor makes a decision in case of disagreement; Statistical analysis was performed while the grouping information was obscured. Lost to visit/exit: Record reasons and time points; The primary analysis included subjects after randomization based on the principle of intentionality, missing outcomes were handled according to the preset rules, and sensitivity analysis results were given. Statistical analysis: In addition to the between-group comparison, the effect size and 95% confidence interval (CI) for the primary outcome were given using a time outcome model (Cox proportional hazards model or accelerated failure model, selected based on data distribution and hypothesis testing results); pH was a repeated measure, and linear mixed-effects models were used to evaluate groups, time, and interaction terms; Significance threshold α = 0.05. Oral pH dynamic monitoring protocol A portable digital pH meter was used for monitoring, with tests taken in the morning and before going to bed each day, and immediately registered after sampling. To minimize interference factors, do not drink water, eat, rinse your mouth, or perform any other oral procedures that may change pH one hour before measurement6. Calibrate with standard buffers (pH 4.00 and pH 7.00) before each measurement, and then sample and read after calibration is qualified; The same subject should be fixed to the same position and sampling site as much as possible to minimize measurement fluctuations. Retest at fixed time points during the intervention cycle and fine-tune the nursing strategy in real time based on the monitoring data. The critical point of intervention is set as follows: ① pH < 6.0 indicates an acidic environment with a higher risk of mucositis, and immediate alkalization and environmental correction measures are required; ② 6.0 ≤ pH < 6.5 is considered a relatively stable range, with emphasis on prevention and maintenance; ③ pH ≥ 6.5 is in the neutral to slightly alkaline range, with emphasis on cleanliness and stability maintenance. Interventions The control group followed the routine of oral care in the hematology department: 2–3 oral evaluations per week and recording of mucosal status and the occurrence of mucositis; For those diagnosed with mucositis, an appropriate gargling plan was selected based on the condition of the wound; Instruct patients to rinse their mouths with 0.12% chlorhexidine or normal saline upon waking up in the morning and after meals; Those with difficulty eating are referred to the nutrition department for individualized diets (liquid or semi-liquid and B vitamin supplements) to reduce nutritional risk7. The observation group added “pH monitoring-stratified intervention” to the above routine process. The nursing team measured saliva pH twice daily and used the values for immediate decision-making. When pH < 6.0, the focus of care shifts to acid neutralization and environmental regulation: instruct the patient to rinse four times in the morning, before going to bed, and after each meal, using either normal saline or 1% − 4% sodium bicarbonate solution for 3–5 min each time; Suspend all oral preparations that may exacerbate acidification. When 6.0 ≤ pH < 6.5, focus on daily maintenance: rinse your mouth three times a day (in the morning, after lunch, before bed), preferably with plain water or mild mouthwash; Reduce high-sugar and high-acid foods in your diet to avoid sharp fluctuations in pH; Pay attention to mucosal moisture daily and encourage short periods of chewing sugar-free gum when dryness and discomfort occur to improve oral humidity. When pH ≥ 6.5, the focus of care is on cleanliness and stability: rinse your mouth once in the morning and once before going to bed, and use regular chlorhexidine mouthwash to consolidate hygiene habits; Be reminded to avoid long-term and excessive intake of highly alkaline beverages such as soda water to prevent excessive environmental fluctuations; Check the pH 1–2 times a week to ensure that the strategy is implemented and adjusted8 promptly. Watch indicators Four core indicators were set in this study, aiming to reflect both the continuous changes in the oral environment and the care process and patient experience. ① Changes in oral pH: A portable digital pH meter was used to measure once in the morning and once before going to bed each day. The original readings, the daily average, and the changes relative to the baseline were recorded, and the measurement time points and intervention execution were retained to restore the dynamic trajectory; ② Incidence of oral mucositis: measured by the proportion of WHO grade ≥ 2 events within a 28-day chemotherapy cycle, determined based on clinical examination and medical records, ulcer diagnosis combined with pain complaint, mucosal damage and redness and swelling signs, and consistency assessment completed by trained nursing staff; ③ Nursing compliance: Using the compliance assessment form developed by the research team, scores were given in dimensions such as gargling on time, diet control, restriction of high acid and high sugar, and maintenance of daily cleanliness. A cumulative score of ≥ 80 points was considered as compliance, and non-compliance items were recorded for subsequent quality improvement. ④ Nursing satisfaction: Using a 100-point questionnaire covering nursing attitude, measure effectiveness, communication quality and individualized implementation, a total score of ≥ 90 was defined as high satisfaction, and open-ended opinions were recorded to supplement the scale information. Statistical methods Data management and analysis were accomplished in the SPSS 26.0 environment. Measurement data were expressed as mean ± standard deviation; Independent sample t-tests were used for comparisons between groups, and paired t-tests were used for paired data before and after the intervention; Count data were expressed as cases and percentages, chi-square test was used for comparisons between groups, and the exact probability method was used when the theoretical frequency was insufficient. All tests were two-sided tests, with the significance threshold set at P < 0.05. To ensure robustness of the results, missing values were processed according to the preset process and sensitivity checks were conducted, and the statistical process was documented for future reference. Research results Relationship between baseline salivation pH and OM in all cohort patients Table 1 presents two baseline PHS: 6.32 ± 0.42 (n = 53) in the occurrence group and 6.17 ± 0.39 (n = 47) in the non-occurrence group. The mean difference was 0.15. t = 1.85, P = 0.067, not reaching the established significance threshold. The standard error based on the t value was approximately 0.081, and the 95% confidence interval was roughly from − 0.011 to 0.311, crossing zero, suggesting insufficient statistical evidence. Cohen’s d, estimated by the combined standard deviation, was about 0.37, a small to moderate effect size, pointing towards slightly higher pH in the occurrence group, but the difference was unstable. The standard deviations of the two groups were close, the variances were roughly matched, and the combined sample size was around 100 cases, resulting in a “critical not significant” outcome, which more indicated limited population predictive power for baseline pH. From a clinical perspective, a pH gap of 0.15 is difficult to support a single admission measurement for universal early warning, and subsequent dynamic monitoring is more valuable. Logistic regression was established with baseline pH as a continuous variable (the model only included pH), with an OR of 2.50 for every 1.0 pH unit increase, 95%CI 0.94–6.59, P = 0.067; converted to every 0.1 pH unit, OR = 1.10, 95%CI 0.99–1.21. The discriminative ability AUC converted approximately by d value is approximately 0.60, which is weak in discrimination, consistent with the judgment that “a single baseline pH is difficult for universal early warning”. Table 1Relationship between baseline salivary pH and OM in the entire cohort (± s) \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline {x}$$\end{document}.Groups n Baseline pHt valueP valueOM occurrence group536.32 ± 0.421.850.067Non-occurrence group476.17 ± 0.39 Table 1Relationship between baseline salivary pH and OM in the entire cohort (± s) \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline {x}$$\end{document}.Groups n Baseline pHt valueP valueOM occurrence group536.32 ± 0.421.850.067Non-occurrence group476.17 ± 0.39 Relationship between baseline salivary pH and OM in the entire cohort (± s) \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline {x}$$\end{document}. Comparison of mucosal healing time in acidic subgroups Table 2 shows that the healing time was 6.8 ± 1.2 days (n = 20) in the intervention group and 11.3 ± 2.1 days (n = 14) in the conventional group, with a mean difference of 4.5 days. t= -7.23, P < 0.001, statistically clear. The standard error estimated by t value was approximately 0.622, and the 95% confidence interval was approximately − 5.77 to -3.23 (as the intervention group minus the conventional group), with the interval completely on the shortened side. The healing time was reduced by approximately 40% compared to the conventional group. The combined standard deviation for Cohen’s d was approximately 2.77, which was a large effect size, statistically significant and clinically significant. For patients in the acidic subgroup, the PH-based individualized alkalization regimen compressed healing from about 11 days to around 7 days, benefiting from pain control, nutrient intake, the window of infection exposure, and reduced resource usage. All 34 cases were followed up after randomization and included in the primary outcome analysis without loss to follow-up. Linear regression results with healing time as the dependent variable and group as the independent variable: β= -4.50 days, SE = 0.62, 95%CI -5.77 to -3.23, P < 0.001 (β direction indicates faster healing in the intervention group). Table 2Comparison of mucosal healing time in acidic subgroups (days, ±s) \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline {x}$$\end{document}.Groups n Mucosal healing timet valueP valueIntervention group206.8 ± 1.2−7.23< 0.001Conventional group1411.3 ± 2.1 Table 2Comparison of mucosal healing time in acidic subgroups (days, ±s) \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline {x}$$\end{document}.Groups n Mucosal healing timet valueP valueIntervention group206.8 ± 1.2−7.23< 0.001Conventional group1411.3 ± 2.1 Comparison of mucosal healing time in acidic subgroups (days, ±s) \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline {x}$$\end{document}. Comparison of saliva pH on the third day of intervention in the acidic subgroup Table 3 presents the pH on the third day of intervention: 6.55 ± 0.15 (n = 20) in the intervention group and 6.20± = 20) for the intervention group and 6.09 ± 0.19 (n = 14) for the conventional group, with a mean difference of 0.46. t = 7.56, P < 0.001. The standard error estimated from the t value was about 0.061, and the 95% confidence interval was about 0.336 to 0.584, which was exactly above zero. The effect size Cohen’s d is about 2.75, which is a maximum effect. Numerically, the intervention group crossed the 6.0 pause threshold on day 3 and was close to the upper edge of the stable range of 6.5, indicating that pH-directed intervention could pull the oral environment from acidic to near neutral at an early stage, creating a more favorable microenvironment for subsequent epithelialization. This echoes the shortened healing time shown in Table 2, suggesting a self-consistent chain of mechanisms: early alkalization, improved microenvironment, and accelerated repair. Linear regression results with pH on day 3 as the dependent variable and group as the independent variable: β = 0.46, SE = 0.061, 95%CI 0.336 to 0.584, P < 0.001 (β direction indicates higher pH in the intervention group). Table 3Comparison of salivary pH on Day 3 of intervention in acidic subgroups (±s) \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline {x}$$\end{document}.Groups n Day 3 pHt valueP valueIntervention group206.55±0.157.56< 0.001Conventional group146.09±0.19 Table 3Comparison of salivary pH on Day 3 of intervention in acidic subgroups (±s) \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline {x}$$\end{document}.Groups n Day 3 pHt valueP valueIntervention group206.55±0.157.56< 0.001Conventional group146.09±0.19 Comparison of salivary pH on Day 3 of intervention in acidic subgroups (±s) \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline {x}$$\end{document}. Discussion In short, the study focused on the dynamic characteristics of oral pH and the application value9 of stratified care in populations treated with high-dose cytarabine. The full-cohort results showed that the baseline pH at admission was not statistically significant between those with mucositis and those without, and a single measurement was difficult to undertake the task of universal prediction. Chemotherapy-related oral damage is caused by the combined effect of multiple factors such as salivary buffering capacity, oral mucosal barrier status, microbiota, individual metabolism and dietary habits. Baseline pH only provides information on a time cross-section and is difficult to capture the trajectory10 of risk evolution. This finding suggests that early warning strategies should shift from static indicators to process-oriented continuous monitoring, with more emphasis on temporal variations and threshold crossings rather than relying on single-point readings. The core approach to mucositis management in nursing guidelines leans more towards “continuous assessment + basic care + risk stratification”, and clinical implementation places more emphasis on repeatable assessment chains and triggering care actions rather than setting a single indicator as an absolute switch. When pH monitoring is incorporated into the routine assessment sequence, changes in readings can be captured in a timely manner, and nursing actions can follow the changes. This logic is more in line with the management path advocated by the guidelines. In terms of the pathological process, mucosal damage often begins with the accumulation of microenvironment and inflammatory signals, followed by visible ulcer phenotypes; Single baseline readings are more likely to be diluted by “differences in drinking, eating, and oral hygiene on the same day,” and continuous trajectories are more likely to show true trends. In the acidic subgroup, individualized alkalization measures guided by dynamic monitoring led to early and stable environmental corrections, with a significant increase in pH on the third day of intervention and healing time reduced by nearly half compared to the conventional regimen. The acidic microenvironment tended to maintain inflammatory signals, hindered migration and proliferation of marginal epithelial cells, enhanced proteolytic activity, and slowed11 tissue regeneration. Rapidly pulling pH back to near neutral reduces the activity of the sensitizing enzyme system and local irritation, reduces the burden of pain, restores eating and oral movement, and makes the body’s repair resources more focused on epithelialization itself. The improvement at the data level corroborates the smooth experience of the clinical process, indicating that the closed-loop model of “monitoring - judgment - intervention - retesting - re-optimization” is feasible, the care path is clearer, and resource utilization is more economical12. From a practical perspective, the pH reading is not just a record item, but a decision switch. When the reading is below the set threshold, alkalization and environmental rectification are triggered; when the reading rebounds, maintenance is initiated to avoid excessive intervention13. This rhythm keeps care in sync with the pathological state, reducing the time consumed by empirical trial and error. External randomized controlled evidence also points in the direction of “measurable indicators leading interventions - improved outcomes.” The Hassanein study team conducted a three-blind randomized trial in a population with radiotherapy-associated oral mucositis of head and neck tumors. Oral suspension of L-arginine or glutamine decreased mucositis grade and pain VAS score compared with placebo, inhibited BMI decline, and improved14 quality of life scale score. The results suggest a quantifiable association between supportive measures and clinical outcomes; The study observed a rise in pH and accelerated healing in the persistent acidic subgroup, which is in line with this evidence trend. For hematology wards, shortened healing cycles mean reduced anti-infection stress, lower demand for intravenous nutrition and analgesia, optimized expected length of hospital stay, and improved subjective feelings and compliance of patients. Uniform training, standardized measurements and imaging traceability make the assessment more consistent and quality control more manageable.